Mechanisms of emphysema in α1-antitrypsin deficiency: Molecular and cellular insights

Bibekbrata Gooptu, U.I. Ekeowa, D.A. Lomas

    Research output: Contribution to journalArticlepeer-review

    116 Citations (Scopus)

    Abstract

    The severe, early onset emphysema that occurs in patients with circulating deficiency of α-antitrypsin (α-AT) attests to the importance of this protease inhibitor in maintaining lung parenchymal integrity. It has led to the powerful concept of protease:antiprotease balance being crucial to alveolar homeostasis. Pathogenic mutations cause α-AT to self-associate into polymer chains that accumulate intracellularly rather than proceeding along the secretory pathway. Polymerisation of α-AT abolishes antiprotease activity and confers toxic gain-of-function effects. Since α-AT is predominantly synthesised in the liver, where it does not play a major homeostatic role, the directly toxic effects of polymerisation are clearest here. However, data from molecular, cellular, animal and ex vivo studies indicate that intrapulmonary polymerisation of α-AT and inflammatory positive feedback loops may augment the destructive effects of decreased antiprotease levels in the lung. This review integrates the findings from these different approaches and highlights how multiple pathways may converge to give the severe, panacinar emphysema phenotype seen in α-AT deficiency. Copyright
    Original languageEnglish
    Pages (from-to)475-488
    Number of pages14
    JournalEuropean Respiratory Journal
    Volume34
    Issue number2
    DOIs
    Publication statusPublished - 1 Aug 2008

    Fingerprint

    Dive into the research topics of 'Mechanisms of emphysema in α1-antitrypsin deficiency: Molecular and cellular insights'. Together they form a unique fingerprint.

    Cite this